ARCHIVES

FDA Rejects Genentech Bid For Accelerated Approval For T-DM1. NCI Breaks Ground For Satellite Campus At Shady Grove

This article is from The Cancer Letter archive.

Vol. 36 No. 31 | September 3, 2010

Download PDF Visit The Full Archive

Related Articles

Radium 223 Dichloride Reduces Death Risk By 30 Percent in Castration-Resistant Disease

August 30, 2013

In Brief: NCAB Schedules Full Day Of AIDS Discussion; PBS To Show Documentary On Tobacco Issues

November 6, 1987

Taking Tykerb With Food Increased Drug Concentration; Paper Urges More Research

July 27, 2007

AMA, ACOS, VA Express Interest In Trials; NCI, DCT Board Cool

March 3, 1989

In Brief: Coalition Begins Campaign To Educate Public

February 3, 1995

Oblimersen Combination Improves CLL Survival

December 28, 2007